Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Adam

Showing results (1121-1130 of 1,232) with videos related to

Pageof 124
Sort By:
The Lancet. Neurology|February 20, 2018
The effect of LRRK2 mutations on the cholinergic system in manifest and premanifest stages of Parkinson's disease: a cross-sectional PET studyShu-Ying Liu, Daryl J Wile, Jessie Fanglu Fu, et al.
Scientific Data|July 18, 2024
CoRRE Trait Data: A dataset of 17 categorical and continuous traits for 4079 grassland species worldwideKimberly J Komatsu, Meghan L Avolio, Josep Padullés Cubino, et al.
Medrxiv : the Preprint Server for Health Sciences|October 27, 2022
Fluvoxamine for Outpatient Treatment of COVID-19: A Decentralized, Placebo-controlled, Randomized, Platform Clinical TrialMatthew W McCarthy, Susanna Naggie, David R Boulware, et al.
Neuroimage. Clinical|December 20, 2020
A prospective cohort study of prodromal Alzheimer's disease: Prospective Imaging Study of Ageing: Genes, Brain and Behaviour (PISA)Michelle K Lupton, Gail A Robinson, Robert J Adam, et al.
JAMA|January 12, 2023
Effect of Fluvoxamine vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical TrialMatthew W McCarthy, Susanna Naggie, David R Boulware, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 9, 2017
Improved survival using specialized multidisciplinary board in sarcoma patientsJ-Y Blay, P Soibinet, N Penel, et al.
JAMA|October 21, 2022
Effect of Ivermectin vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical TrialSusanna Naggie, David R Boulware, Christopher J Lindsell, et al.
Medrxiv : the Preprint Server for Health Sciences|August 20, 2025
Metformin on the Presence of COVID-19 Symptoms Over 6 Months: The ACTIV-6 Randomized Clinical TrialCarolyn T Bramante, Thomas G Stewart, David R Boulware, et al.
Medrxiv : the Preprint Server for Health Sciences|December 23, 2022
Effect of Ivermectin 600 μg/kg for 6 days vs Placebo on Time to Sustained Recovery in Outpatients with Mild to Moderate COVID-19: A Randomized Clinical TrialSusanna Naggie, David R Boulware, Christopher J Lindsell, et al.
American Journal of Respiratory Cell and Molecular Biology|October 1, 2013
Lung phenotype of juvenile and adult cystic fibrosis transmembrane conductance regulator-knockout ferretsXingshen Sun, Alicia K Olivier, Bo Liang, et al.
Pageof 124

Showing results (1121-1130 of 1,232) with videos related to

Sort By:
Pageof 124
The Lancet. Neurology|February 20, 2018
The effect of LRRK2 mutations on the cholinergic system in manifest and premanifest stages of Parkinson's disease: a cross-sectional PET studyShu-Ying Liu, Daryl J Wile, Jessie Fanglu Fu, et al.
Scientific Data|July 18, 2024
CoRRE Trait Data: A dataset of 17 categorical and continuous traits for 4079 grassland species worldwideKimberly J Komatsu, Meghan L Avolio, Josep Padullés Cubino, et al.
Medrxiv : the Preprint Server for Health Sciences|October 27, 2022
Fluvoxamine for Outpatient Treatment of COVID-19: A Decentralized, Placebo-controlled, Randomized, Platform Clinical TrialMatthew W McCarthy, Susanna Naggie, David R Boulware, et al.
Neuroimage. Clinical|December 20, 2020
A prospective cohort study of prodromal Alzheimer's disease: Prospective Imaging Study of Ageing: Genes, Brain and Behaviour (PISA)Michelle K Lupton, Gail A Robinson, Robert J Adam, et al.
JAMA|January 12, 2023
Effect of Fluvoxamine vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical TrialMatthew W McCarthy, Susanna Naggie, David R Boulware, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 9, 2017
Improved survival using specialized multidisciplinary board in sarcoma patientsJ-Y Blay, P Soibinet, N Penel, et al.
JAMA|October 21, 2022
Effect of Ivermectin vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical TrialSusanna Naggie, David R Boulware, Christopher J Lindsell, et al.
Medrxiv : the Preprint Server for Health Sciences|August 20, 2025
Metformin on the Presence of COVID-19 Symptoms Over 6 Months: The ACTIV-6 Randomized Clinical TrialCarolyn T Bramante, Thomas G Stewart, David R Boulware, et al.
Medrxiv : the Preprint Server for Health Sciences|December 23, 2022
Effect of Ivermectin 600 μg/kg for 6 days vs Placebo on Time to Sustained Recovery in Outpatients with Mild to Moderate COVID-19: A Randomized Clinical TrialSusanna Naggie, David R Boulware, Christopher J Lindsell, et al.
American Journal of Respiratory Cell and Molecular Biology|October 1, 2013
Lung phenotype of juvenile and adult cystic fibrosis transmembrane conductance regulator-knockout ferretsXingshen Sun, Alicia K Olivier, Bo Liang, et al.
Pageof 124